Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.38 USD
Change Today -0.10 / -0.80%
Volume 1.5M
MACK On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 5:20 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitleKey Developments
Gordon Fehr Ph.D. 16 RelationshipsDirector, Chairman of Organization & Compensation Committee and Member of Audit Committee 
James Quigley 289 RelationshipsDirector and Chairman of Audit Committee 
Russell Ray 50 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitle
Gordon Fehr Ph.D. 16 RelationshipsDirector, Chairman of Organization & Compensation Committee and Member of Audit Committee
Vivian Lee M.D., Ph.D., M.B.A. 16 RelationshipsDirector and Member of Organization & Compensation Committee
John Mendelsohn M.D. 166 RelationshipsDirector and Member of Organization & Compensation Committee
MACK Compensation vs. Industry
512.7K
317.1K
Chief Executive Officer
284.6K
227.3K
Chief Financial Officer
343.3K
284.2K
Chief Operating Officer
Share price activity for MERRIMACK PHARMACEUTICALS IN (MACK)
52 Week Price Performance
MACK
Industry Average

Nominating Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitleKey Developments
Gary Crocker 62 RelationshipsChairman, Chairman of Executive Committee and Member of Corporate Governance & Nominating CommitteeMerrimack Pharmaceuticals, Inc. Announces Executive Changes, Effective January 30, 2015
01/22/15

Corporate Governance Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitle
Gary Crocker 62 RelationshipsDirector, Chairman of Organization & Compensation Committee and Member of Audit Committee
MACK and Competitor
Insiders vs. External
Board
12%
88%
Merrimack Pharmaceuticals, Inc.
Insiders
External Board Members

Executive Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitle
Gary Crocker 62 RelationshipsChairman, Chairman of Executive Committee and Member of Corporate Governance & Nominating Committee
Robert Mulroy 16 RelationshipsChief Executive Officer, President, Executive Director and Member of Executive Committee
Michael Porter Ph.D. 50 RelationshipsStrategy Advisor, Director, Chairman of Corporate Governance & Nominating Committee and Member of Executive Committee
Management Effectiveness Relative to the Industry
Return on Equity
33.8x
Return on Assets
145.5x
Return on Total Capital
NM
TEV/Total Revenue(LTM)
NM

Advisory Committee* - merrimack pharmaceuticals in (MACK)

Name (Board Relationships)/Title Board Affiliations
Christopher Benz 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Douglas Lauffenburger 67 Relationships
Member of Scientific Advisory Board
No other board affiliations
James Marks 53 Relationships
Member of Scientific Advisory Board
No other board affiliations
John Park 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Barret Rollins 29 Relationships
Member of Scientific Advisory Board
No other board affiliations
Peter Sorger 39 Relationships
Chairman of Scientific Advisory Board
No other board affiliations
Louis Weiner 64 Relationships
Member of Scientific Advisory Board
No other board affiliations
Michael Yaffe 58 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MACK:US $12.38 USD -0.10

MACK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MACK.
View Industry Companies
 

Industry Analysis

MACK

Industry Average

Valuation MACK Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRIMACK PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.